The Cancer Letter

Inside information on cancer research and drug development

Vol.
20
No.
34
September 09, 1994Sep 09, 1994
Free
DOWNLOAD THE PDF

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

PCI Files Application For Research Base COP

Eight applications Received For NSABP chairman

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

Broder, Herberman, Decline To Coauthor Reanalysis of Data

“I Can’t Permit Destruction of NSABP,” Fisher Writes

Herberman: Progress Made To Stabilize NSABP

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account